GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Cash Flow from Financing

CryoPort (CryoPort) Cash Flow from Financing : $-23.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is CryoPort Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, CryoPort paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $0.1 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It spent $0.0 Mil on other financial activities. In all, CryoPort spent $0.1 Mil on financial activities for the three months ended in Dec. 2023.


CryoPort Cash Flow from Financing Historical Data

The historical data trend for CryoPort's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Cash Flow from Financing Chart

CryoPort Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.15 385.59 564.34 -39.17 -23.80

CryoPort Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.31 0.07 1.15 -24.89 -0.13

CryoPort Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

CryoPort's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

CryoPort's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CryoPort  (NAS:CYRX) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

CryoPort's issuance of stock for the three months ended in Dec. 2023 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

CryoPort's repurchase of stock for the three months ended in Dec. 2023 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

CryoPort's net issuance of debt for the three months ended in Dec. 2023 was $-0.1 Mil. CryoPort spent $0.1 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

CryoPort's net issuance of preferred for the three months ended in Dec. 2023 was $0.0 Mil. CryoPort paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

CryoPort's cash flow for dividends for the three months ended in Dec. 2023 was $0.0 Mil. CryoPort received $0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

CryoPort's other financing for the three months ended in Dec. 2023 was $-0.0 Mil. CryoPort spent $0.0 Mil on other financial activities.


CryoPort Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of CryoPort's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


CryoPort (CryoPort) Business Description

Traded in Other Exchanges
Address
112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Executives
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton director, officer: President, CEO C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman director 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich officer: Chief Financial Officer
Mark W Sawicki officer: Chief Scientific Officer 3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p. 10 percent owner C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock director 7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini director 20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam director 4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath director C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman 10 percent owner C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154